Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized trial of Avastin with gemcitabine versus Avastin with cisplatin + gemcitabine in elderly first-line non-squamous NSCLC
2008-008739-27Phase 2Completed
- Sponsor
- Roche
- Start
- Aug 2009
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Non-small cell lung cancer (NS-NSCLC) comparing Avastin + gemcitabine with Avastin + cisplatin + gemcitabine (2 arms). Primary endpoint: 6-month progression-free rate. Started Aug 2009; status: completed.
02
Drugs
bevacizumabgemcitabinecisplatin
03
Conditions
Non-small cell lung cancer (NS-NSCLC)
Beyond the preview
Go deeper on 2008-008739-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008739-27.